Advertisement
Original article| Volume 170, P22-30, April 2023

Frequency and type of premature or early menopause in a geographically defined American population

  • Walter A. Rocca
    Correspondence
    Corresponding author at: Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States.
    Affiliations
    Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States

    Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States

    Women's Health Research Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States
    Search for articles by this author
  • Liliana Gazzuola Rocca
    Affiliations
    Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States
    Search for articles by this author
  • Carin Y. Smith
    Affiliations
    Division of Clinical Trials and Biostatistics, Department of Quantitative Health Sciences, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States
    Search for articles by this author
  • Ekta Kapoor
    Affiliations
    Women's Health Research Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States

    Division of General Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States

    Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States

    Center for Women's Health, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States
    Search for articles by this author
  • Stephanie S. Faubion
    Affiliations
    Center for Women's Health, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States

    Division of General Internal Medicine, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, United States
    Search for articles by this author
  • Elizabeth A. Stewart
    Affiliations
    Women's Health Research Center, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States

    Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States

    Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States
    Search for articles by this author

      Highlights

      • In the study's random sample of women aged 18 to 50 years who resided in Olmsted County between 1988 and 2007, median age was 51 years for spontaneous and 46 years for induced menopause.
      • The frequency of premature spontaneous or induced menopause was 3.1 %.
      • Bilateral oophorectomy was the most common cause of premature menopause.
      • Hysterectomy with at least one ovary conserved concealed the onset of menopause.
      • Gynecologic surgeries for benign conditions should be reduced.

      Abstract

      Objective

      There is limited information on the prevalence of premature and early menopause. Therefore, we studied the frequency and type of premature (age < 40 years) or early (age 40–44 years) menopause in a geographically-defined American population.

      Methods

      We studied a random sample of women aged 18 to 50 years who resided in Olmsted County, MN between 1988 and 2007. Women were followed through December 2021, and age at cessation of menses was assessed via review of the medical records included in a medical records-linkage system. Menopause was defined as cessation of menses due to spontaneous or induced ovarian insufficiency.

      Results

      1015 women (71.3 %) underwent spontaneous menopause, 138 (9.7 %) underwent bilateral oophorectomy, 17 (1.2 %) had antecedent chemotherapy or radiation therapy, and 254 (17.8 %) underwent hysterectomy or endometrial ablation. The median age at cessation of menses was 51.0 years (IQR, 49.0–52.0) for spontaneous menopause, 46.0 years (IQR, 41.0–49.0) for menopause induced by oophorectomy, chemotherapy, or radiation therapy, and 38.0 years (IQR, 33.0–44.0) for hysterectomy. Considering both spontaneous and induced menopause, the frequency was 3.1 % (95 % CI, 2.2–4.2) for premature and 6.2 % (95 % CI, 5.0–7.8) for early menopause. Considering only spontaneous menopause, the frequency reduced to 0.4 % (95 % CI, 0.2–1.0) for premature and 5.2 % (95 % CI, 4.0–6.8) for early menopause. However, considering all types of cessations of menses, the frequency was 12.2 % (95 % CI, 10.6–14.0) for premature and 9.7 % (95 % CI, 8.3–11.3) for early cessation of menses.

      Discussion

      Approximately 3 % of women in the general population experienced either spontaneous or induced premature menopause. The most common cause of premature menopause was bilateral oophorectomy.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Golezar S.
        • Ramezani Tehrani F.
        • Khazaei S.
        • Ebadi A.
        • Keshavarz Z.
        The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis.
        Climacteric. 2019; 22: 403-411
        • Rocca W.A.
        • Mielke M.M.
        • Gazzuola Rocca L.
        • Stewart E.A.
        Premature or early bilateral oophorectomy: a 2021 update.
        Climacteric. 2021; 24: 466-473
        • Erickson Z.
        • Rocca W.A.
        • Smith C.Y.
        • Gazzuola Rocca L.
        • Stewart E.A.
        • Laughlin-Tommaso S.K.
        • Mielke M.M.
        Time trends in unilateral and bilateral oophorectomy in a geographically defined American population.
        Obstet. Gynecol. 2022; 139: 724-734
        • Stewart E.A.
        • Missmer S.A.
        • Rocca W.A.
        Moving beyond reflexive and prophylactic gynecologic surgery.
        Mayo Clin. Proc. 2021; 96: 291-294
        • Laughlin-Tommaso S.K.
        • Stewart E.A.
        • Grossardt B.R.
        • Gazzuola Rocca L.
        • Rocca W.A.
        Incidence, time trends, laterality, indications, and pathological findings of unilateral oophorectomy before menopause.
        Menopause. 2014; 21: 442-449
        • Rocca W.A.
        • Gazzuola-Rocca L.
        • Smith C.Y.
        • Grossardt B.R.
        • Faubion S.S.
        • Shuster L.T.
        • Kirkland J.L.
        • Stewart E.A.
        • Miller V.M.
        Accelerated accumulation of multimorbidity after bilateral oophorectomy: a population-based cohort study.
        Mayo Clin. Proc. 2016; 91: 1577-1589
        • Rocca W.A.
        • Gazzuola Rocca L.
        • Smith C.Y.
        • Grossardt B.R.
        • Faubion S.S.
        • Shuster L.T.
        • Stewart E.A.
        • Mielke M.M.
        • Kantarci K.
        • Miller V.M.
        Cohort profile: the Mayo Clinic Cohort Study of Oophorectomy and Aging-2 (MOA-2) in Olmsted County, Minnesota (USA).
        BMJ Open. 2017; 7e018861
        • World Health Organization
        Research on the menopause in the 1990s.
        in: Report of a WHO Scientific Group, World Health Organ. Tech. Rep. Ser. 866. 1996: 1-107
        • The North American Menopause Society
        Menopause Practice: A Clinician's Guide.
        6th ed. NAMS, Mayfield Heights, OH2022
        • St Sauver J.L.
        • Grossardt B.R.
        • Yawn B.P.
        • Melton III, L.J.
        • Rocca W.A.
        Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project.
        Am. J. Epidemiol. 2011; 173: 1059-1068
        • St Sauver J.L.
        • Grossardt B.R.
        • Yawn B.P.
        • Melton III, L.J.
        • Pankratz J.J.
        • Brue S.M.
        • Rocca W.A.
        Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.
        Int. J. Epidemiol. 2012; 41: 1614-1624
        • Rocca W.A.
        • Yawn B.P.
        • St Sauver J.L.
        • Grossardt B.R.
        • Melton L.J.
        3rd, history of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.
        Mayo Clin. Proc. 2012; 87: 1202-1213
        • Rocca W.A.
        • Grossardt B.R.
        • Brue S.M.
        • Bock-Goodner C.M.
        • Chamberlain A.M.
        • Wilson P.M.
        • Rutten L.J.Finney
        • Sauver J.L.St
        Data resource profile: expansion of the Rochester Epidemiology Project medical records-linkage system (E-REP).
        Int. J. Epidemiol. 2018; 47 (368-368j)https://doi.org/10.1093/ije/dyx268
        • Utian W.H.
        Semantics, menopause-related terminology, and the STRAW reproductive aging staging system.
        Menopause. 2001; 8: 398-401
        • Rocca W.A.
        • Grossardt B.R.
        • Shuster L.T.
        Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity.
        Brain Res. 2011; 1379: 188-198
        • Jiao X.
        • Zhang H.
        • Ke H.
        • Zhang J.
        • Cheng L.
        • Liu Y.
        • Qin Y.
        • Chen Z.J.
        Premature ovarian insufficiency: phenotypic characterization within different etiologies.
        J. Clin. Endocrinol. Metab. 2017; 102: 2281-2290
        • Lambrinoudaki I.
        • Paschou S.A.
        • Lumsden M.A.
        • Faubion S.
        • Makrakis E.
        • Kalantaridou S.
        • Panay N.
        Premature ovarian insufficiency: a toolkit for the primary care physician.
        Climacteric. 2021; 24: 425-437
      1. The 2022 hormone therapy position statement of The North American Menopause Society.
        Menopause. 2022; 29: 767-794https://doi.org/10.1097/gme.0000000000002028
        • de Villiers T.J.
        • Hall J.E.
        • Pinkerton J.V.
        • Pérez S.Cerdas
        • Rees M.
        • Yang C.
        • Pierroz D.D.
        Revised global consensus statement on menopausal hormone therapy.
        Climacteric. 2016; 19: 313-315https://doi.org/10.1080/13697137.2016.1196047
        • Kaunitz A.M.
        • Kapoor E.
        • Faubion S.
        Treatment of women after bilateral salpingo-oophorectomy performed prior to natural menopause.
        JAMA. 2021; 326: 1429-1430https://doi.org/10.1001/jama.2021.3305
        • Rocca W.A.
        • Bower J.H.
        • Maraganore D.M.
        • Ahlskog J.E.
        • Grossardt B.R.
        • de Andrade M.
        • Melton III, L.J.
        Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.
        Neurology. 2007; 69: 1074-1083
        • Laughlin-Tommaso S.K.
        • Khan Z.
        • Weaver A.L.
        • Smith C.Y.
        • Rocca W.A.
        • Stewart E.A.
        Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study.
        Menopause. 2018; 25: 483-492
        • Trabuco E.C.
        • Moorman P.G.
        • Algeciras-Schimnich A.
        • Weaver A.L.
        • Cliby W.A.
        Association of ovary-sparing hysterectomy with ovarian reserve.
        Obstet. Gynecol. 2016; 127: 819-827
        • Coslov N.
        • Richardson M.K.
        • Woods N.F.
        Symptom experience during the late reproductive stage and the menopausal transition: observations from the women living better survey.
        Menopause. 2021; 28: 1012-1025
        • Laughlin-Tommaso S.K.
        • Smith C.Y.
        • Weaver A.L.
        • Khan Z.
        • Stewart E.A.
        • Rocca W.A.
        In reply.
        Menopause. 2019; 26: 112-114
        • Rocca W.A.
        • Rocca L.Gazzuola
        • Smith C.Y.
        • Grossardt B.R.
        • Faubion S.S.
        • Shuster L.T.
        • Kirkland J.L.
        • LeBrasseur N.K.
        • Schafer M.J.
        • Mielke M.M.
        • Kantarci K.
        • Stewart E.A.
        • Miller V.M.
        Loss of ovarian hormones and accelerated somatic and mental aging.
        Physiology (Bethesda). 2018; 33: 374-383https://doi.org/10.1152/physiol.00024.2018